1. Adocia (13 from 42 patents)

1. 12421327 - Hydrogels for cell therapy

2. 12186373 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

3. 11883496 - Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

4. 11633460 - Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

5. 11191812 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

6. 11173109 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid

7. 11129877 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

8. 10987426 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

9. 10548952 - Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

10. 10485851 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

11. 10383918 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid

12. 10383920 - Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

13. 9089476 - Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5